TCM Treatment and Drug Co-Occurrence Analysis of Psoriasis.

Li Lin, Suqing Yang, Qingsong Bai, Yuepeng An

RetractedAbstract readRetracted Publication

In one paragraph

Article in Computational intelligence and neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Retracted: TCM Treatment and Drug Co-Occurrence Analysis of Psoriasis.Computational intelligence and neuroscience · 2023
Article

4 · The record

Corrections and comments

Retraction · 2023-07-26Concerns/Issues about Data · Concerns/Issues about Referencing/Attributions · Concerns/Issues about Results and/or Conclusions · Concerns/Issues about Peer Review · Informed/Patient Consent - None/Withdrawn · Investigation by Journal/Publisher · Lack of IRB/IACUC Approval and/or Compliance · Unreliable Results and/or Conclusions ·
Retracted
Retracted: TCM Treatment and Drug Co-Occurrence Analysis of Psoriasis.2023

5 · Who and what money

Authors and funding

4 authors.

Li LinSchool of Graduate, Heilongjiang University of Chinese Medicine, Harbin 150040, Heilongjiang, China.ORCID https://orcid.org/0000-0002-3402-046X

Suqing YangDepartment of Dermatology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin 150040, Heilongjiang, China.

Qingsong BaiSchool of Graduate, Heilongjiang University of Chinese Medicine, Harbin 150040, Heilongjiang, China.

Yuepeng AnDepartment of Dermatology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin 150040, Heilongjiang, China.ORCID https://orcid.org/0000-0003-0022-5296

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psoriasis is a long-term immune-mediated disease. Patients with a long history and slow progress are more common, and its treatment is difficult. This study proposes to use traditional Chinese medicine to treat psoriasis. Through the follow-up of all participants for 12 and 24 weeks, a large number of comparative experiments effectively verify the effectiveness of the method proposed in this study. The research results of this study can provide some reference ideas for follow-up research.

Indexed as

Drugs, Chinese HerbalPsoriasisHumansMedicine, Chinese TraditionalResearch DesignDrugs, Chinese Herbal

Identifiers

PMID35132314

DOI10.1155/2022/4268681

PMCPMC8817851

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.